a slight trendp=0.02
On the other hand, germline POL + lung cancers showed increased association between high TMB and FLT1 alterations, and a slight trend towards reduced TMB in cases with oncogenic driver mutations in EGFR , ERBB2 , and KRAS (FLT1, p=0.02; oncogenic driver mutations, p=0.28; Fisher’s exact tests).